Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study Prof Vallerie V McLaughlin, MDa ∙ Derek Solum, PhDb ∙ Daniel Lachant, DOc ∙ Prof Ali Ataya, MD MBAd ∙ Joan A Barberà, MD PhDe ∙ Gisela Bohns Meyer, MDf ∙ et al.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study Prof Vallerie V McLaughlin, MDa ∙ Derek Solum, PhDb ∙ Daniel Lachant, DOc ∙ Prof Ali Ataya, MD MBAd ∙ Joan A Barberà, MD PhDe ∙ Gisela Bohns Meyer, MDf ∙ et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01011-1/fulltext?dgcid=raven_jbs_etoc_feature_lancet